The Recent Updates on Approaches and Clinical Trials Status of Covid-19 Vaccines Developed Globally
Sachin Chaudhary1*, Abdel-Nasser El-Shorbagi1
, Ramesh Kumar Gupta2 and Amit Kumar31Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates, 27272
2Department of Pharmacology, Hygia Institute of Pharmaceutical Education and Research Lucknow, Uttar Pradesh, India, 226020
3School of Pharmaceutical Sciences, IIMT University, Meerut, Uttar Pradesh, India, 250001
Corresponding Author E-mail: schaudhary@sharjah.ac.ae
Abstract: The Covid-19 pandemic since 2019 has imparted a massive influence on the human life around the world, irrespective of all the precautionary measures followed worldwide it is strongly suggested that only the effective and safer vaccine can control this vicious pandemic. Nevertheless, the vaccine development strategies for Covid-19 was initiated firstly in china after the outbreak of Covid-19 and then globally after it was declared as pandemic by World Health Organization. Currently, numerous platforms have been designed for developing the most efficacious and safe vaccines designed by different technologies including protein subunit, viral vector, RNA, DNA, inactivated, and live attenuated approach. Here, this review will illustrates the detailed information on above mentioned Covid-19 vaccines development technologies, protocols and their clinical trial phase status. Additionally, this review also includes the details of vaccines failed to progress further.
Keywords: Clinical trial; Covid-19; Inactivated; Live attenuated; SARS-CoV-2; Vaccine Back to TOC